ArticleOncotarget2015

EGFR tyrosine kinase inhibitors promote pro-caspase-8 dimerization that sensitizes cancer cells to DNA-damaging therapy.

Yun-Tian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.